Reduction of Medication Costs After Detoxification for Medication-Overuse Headache
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Reduction of Medication Costs After Detoxification for Medication-Overuse Headache. / Shah, Asif M; Bendtsen, Lars; Zeeberg, Peter; Jensen, Rigmor H.
I: Headache, 2013.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Reduction of Medication Costs After Detoxification for Medication-Overuse Headache
AU - Shah, Asif M
AU - Bendtsen, Lars
AU - Zeeberg, Peter
AU - Jensen, Rigmor H
N1 - © 2012 American Headache Society.
PY - 2013
Y1 - 2013
N2 - OBJECTIVE: To examine whether detoxifying patients with medication-overuse headache can reduce long-term medication costs. BACKGROUND: Direct costs of medications in medication-overuse headache have been reported to be very high but have never been calculated on the basis of exact register data. Long-term economic savings obtained by detoxification have never been investigated. METHODS: We conducted a registry-based observational retrospective follow-up study on 336 medication-overuse headache patients treated and discharged from the Danish Headache Center over a 2-year period. By means of the Danish Register of Medicinal Product Statistics, we collected information on the costs and use of prescription-only medication 1 year before admission and 1 year after discharge from Danish Headache Center. RESULTS: The average medication costs per patient per year decreased with 24%, from US$971 before treatment to US$737 after (P = .001), and the average medication use decreased with 14.4% (P = .02). Savings were most pronounced for patients overusing triptans. In this group, the average medication costs per patient per year decreased with 43% (P
AB - OBJECTIVE: To examine whether detoxifying patients with medication-overuse headache can reduce long-term medication costs. BACKGROUND: Direct costs of medications in medication-overuse headache have been reported to be very high but have never been calculated on the basis of exact register data. Long-term economic savings obtained by detoxification have never been investigated. METHODS: We conducted a registry-based observational retrospective follow-up study on 336 medication-overuse headache patients treated and discharged from the Danish Headache Center over a 2-year period. By means of the Danish Register of Medicinal Product Statistics, we collected information on the costs and use of prescription-only medication 1 year before admission and 1 year after discharge from Danish Headache Center. RESULTS: The average medication costs per patient per year decreased with 24%, from US$971 before treatment to US$737 after (P = .001), and the average medication use decreased with 14.4% (P = .02). Savings were most pronounced for patients overusing triptans. In this group, the average medication costs per patient per year decreased with 43% (P
U2 - 10.1111/head.12031
DO - 10.1111/head.12031
M3 - Journal article
JO - Headache
JF - Headache
SN - 0017-8748
ER -
ID: 48425386